A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers
Stephanie Guerra(Brigham and Women's Hospital), Karen Cichowski(Brigham and Women's Hospital), Sandro Santagata(Harvard University), Caroline J. Guild(Brigham and Women's Hospital), Hong L. Tiv, Stephen J. Elledge(Howard Hughes Medical Institute), Pasi A. Jänne(Harvard University), Man Xu, Amanda J. Redig(Brigham and Women's Hospital), Richard O. Adeyemi(University of Missouri), Ryan Kuzmickas(Brigham and Women's Hospital), Shawna Guillemette(Brigham and Women's Hospital), Emily S. Chambers(Dana-Farber Cancer Institute), Ophélia Maertens(American Institutes for Research), Thomas De Raedt(Children's Hospital of Philadelphia)
Cited by 56
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k